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Background: Individuals with knee osteoarthritis (OA) demonstrate impairments in muscle function 
(i.e. muscle weakness, high muscle co-activation believed to have detrimental effects on joint 
integrity). Women with knee OA exhibit poorer health outcomes than men. Sex and muscle function 
are known risk factors for knee OA. It is unclear how these risk factors are associated with muscle 
function in knee OA and the implications for disease aetiology.  
Research question: How does sex and knee osteoarthritis disease status relate to muscle function, 
specifically strength and muscle co-activation, during walking, stair negotiation and sit-to-walk 
activities. 
Methods: A cross-sectional study assessed muscle co-activation in 77 individuals with knee OA 
(62.5[8.1]yrs; 48/29 women/men) and 18 age-matched controls (62.5[10.4]yrs; 9/9 women/men), 
during a series of walking, stair ascent and descent and sit-to-walk activities. Muscle strength of the 
knee extensors and flexors was assessed using maximal voluntary isometric contractions (MVIC). 
Electromyography was recorded from the vastus lateralis/medalis, rectus femoris, biceps femoris, 
semitendinosus, medial/lateral gastrocnemius normalised to MVIC. Multiple regression assessed the 
relationship between sex, disease status, and muscle strength on muscle co-activation. 
Results: Individuals with knee OA were weaker than controls, had higher hamstrings-quadriceps and 
medial-lateral co-activation for specific phases of gait. Women were weaker than men with higher 
muscle co-activation across all activities. Sex and muscle weakness, but not age or disease status 
predicted high muscle co-activation. 
Significance: High muscle co-activation was associated with female sex and muscle weakness 
regardless of disease status and age. High muscle co-activation is believed to be a compensatory 
mechanism for muscle weakness to maintain a certain level of function. High muscle co-activation is 
also thought to have detrimental effects on cartilage and joint integrity this may explain high muscle 
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co-activation in women with muscle weakness and contribute to increased risk of incidence and 
progression of knee OA in women. 
 





Female sex and muscle weakness are known risk factors for the development of symptomatic knee 
osteoarthritis (OA) [1]. A meta-analysis of sex-difference in knee OA found reduced prevalence (Risk 
Ratio [RR] 0.63, 95% CI 0.53-0.75) and incidence (RR 0.55, 95% CI 0.32-0.95) in men, with prevalent 
knee OA significantly more severe in women (standardised mean difference 0.20, 95% CI 0.11-0.28)[2]. 
There are several possible explanations for sex differences in individuals with knee OA, including 
increased joint loading in women as a result of increased weight gain during and following the 
menopause, and changes in joint angles caused by wider hips, which alters the joint biomechanics [3]. 
Additionally, differences in sex hormones specifically ovarian hormones effects on joint health and 
muscle function, although research remains unclear, hormone replacement therapy demonstrates 
positive effects on knee OA [4]. The increased loading and biomechanical alterations are often 
accompanied by changes in muscle function such as strength, muscle activation, and co-activation 
patterns, due to a greater reliance on the active muscle system for support and control, further 
exacerbated by disease severity [5–7]. 
 
Muscle function in individuals with knee OA is extensively studied as a primary underlying cause of 
functional limitations. Large variations (4-64%) in muscle strength are observed between individuals 
with knee OA and controls, with no differences in muscle strength between OA disease severity 
identified [8,9]. Muscle weakness is associated with altered muscle activation patterns, specifically 
increased amplitude and duration of muscle activation and high muscle co-activation during gait [5]. 
Certain levels of muscle co-activation are required to stabilise the joint [5,10]. High levels of muscle 
co-activation are believed to be detrimental to joint integrity potentially increasing joint load, 
especially when load is focused to a single point rather than distributed across the joint [11]. Several 
cross-sectional studies have shown elevated muscle co-activation in individuals with knee OA during 
gait [5], increasing with disease severity [12], while others have found no difference [13]. This could 
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be a result of methodological differences, whereby Zeni et al. grouped Kellgren and Lawrence grades 
2 and 3 together whereas Rutherford et al. kept each grade separately [12,13]. Moreover, muscle co-
activation was assessed differently with one study using principal component analysis while the other 
used the co-activation index equation [12,13]. During other weight-bearing activities of daily living, 
there remains limited research. Studies exploring activation patterns found elevated muscle co-
activation for stair negotiation [10,14], and sit-to-stand [14,15]; moreover the authors [14] 
demonstrated different co-activation patterns across activities of daily living (gait, stair negotiation, 
sit-to-walk). These elevated levels of muscle co-activation are believed to have detrimental effects on 
joint integrity by increasing the joint load, which exacerbates joint damage [5]. 
 
Sex differences in muscle weakness are seen with knee OA [16–18]. Previous research comparing 
normal-weight and obese adults with knee OA found reduced strength (normalised to body mass) in 
obese women and no difference in men, and while muscle cross-sectional area increased in obese 
men there was no difference in women [16]. These changes in muscle cross-sectional area are 
associated with the composition of the muscle determined from magnetic resonance imaging. Obese 
women had increased intra-muscular fat, reduced muscle fibre tissue and no change in cross-sectional 
area, while the men had no changes in the amount of muscle tissue but increased intra-muscular fat 
explaining the increase in cross-sectional area [16,19]. Sex-hormones modulate knee tissue; however, 
estrogen alone cannot explain the observed sex-differences [20]. The poor prognosis of knee OA in 
women with muscle strength deficits may be explained by sex-specific relationships between muscle-
specific strength and body mass index [16] 
 
The further implications of sex in the relationship between muscle function and knee OA may be able 
to explain why females are at an increased risk of knee OA. Women with knee OA have been shown 
to have poorer health outcomes [21], specifically elevated pain levels [22] and impaired physical and 
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self-reported function [18], compared to men. Reduced muscle function is associated with pain and 
functional limitations and may, therefore, explain these differences [23,24]. 
 
 The purpose of this study was to investigate sex and disease-related differences in muscle function 
(strength and muscle co-activation) in individuals with and without knee OA. It was hypothesised that 
muscle co-activation during weight-bearing activities (gait, stair negotiation, sit-to-walk) will be higher 






Participants were recruited based on sample size calculations of the NEKO study (NCT02314715 
www.clinicaltrials.gov). A sample size calculation for this study based on multiple regression with 
muscle co-activation as the independent variable and four dependent variables (age, sex, strength, 
disease status), effect size of 0.35, alpha 0.05, and 80% power, resulting in a minimum required sample 
size of 39. A convenience sample of adults (aged ≥40years) with doctor-diagnosed unilateral/bilateral 
knee OA, self-reported pain, stiffness lasting <30minutes, were recruited, as well as asymptomatic 
healthy age-matched controls. The presence of knee OA-related structural change (i.e. joint space 
narrowing, osteophytes, bone marrow lesions) was confirmed by magnetic resonance imaging (scored 
based on the Boston Leeds Osteoarthritis Knee Score, data not presented here), and ultrasound 
(sonographer with 12 years clinical experience, data not presented here). Participant recruitment was 
through rheumatology clinics; general practitioners; local newspaper adverts; friends and family of 
individuals with knee OA; the Active Living Database, a Glasgow Caledonian University held database 




Exclusion criteria were: any other neuromuscular skeletal injury or disease; knee replacement; knee 
surgery in the past year; steroid injections in the past three months or severe co-morbidity which 
would interfere with the study. A history of lower limb OA or chronic/stable lower limb pain in the 
past three months (controls only). 
 
All participants gave written informed consent to participate in the study approved by Glasgow 
Caledonian University (HLS12/86) and West of Scotland (13/WS/0146) Research Ethics committees 




Surface electromyography (EMG) was recorded from the vastus medialis and lateralis (VM, VL); rectus 
femoris (RF); semitendinosus (ST); biceps femoris (BF): medial and lateral gastrocnemius (MG, LG) of 
the test leg (Trigno sensors, 99% silver 4 5*1mm bar sensors, fixed inter-electrode distance 10mm, 
Delsys, Boston USA). The most symptomatic knee based on self-report in individuals with knee OA or 
a randomly assigned knee in controls defined the test leg. Based on surface electromyography for the 
non-invasive assessment of muscles recommendations [25], the area was prepared by shaving, lightly 
abrading and cleaning with alcohol. Isolated contractions assessed EMG recordings for signal quality 
and noise. The raw signal passed through a Trigno differential amplifier, input impedance 10,000MΩ, 
common mode rejection ratio >80dB, gain 1,000 with a bandwidth of 20Hz-450Hz and recorded with 
a 16bit analogue-to-digital converter (PCI-DAS6402/16, Measurement computing corporation, 
Massachusetts, USA), at a sampling rate of 2400Hz. All EMG and force data were collected in Qualysis 
Track Manager (version2.7-2.9, Qualysis Motion Capture Systems, Sweden) and processed in Spike2 
(version 2.7.10, Cambridge Electronic Design, Ltd, Cambridge, UK). 
 




During a single visit, participants performed a series of ADL in the following order: stair ascent and 
stair descent; walking; and sit-to-walk transitions, followed by muscle strength assessments. The 
number of trials performed for each activity, as stated below was a pragmatic decision to enable high-
quality data while safeguarding against high levels of fatigue. 
 
A four-step instrumented staircase with a Kistler force plate (9286BA, Kistler, Switzerland) embedded 
into the second step and aligned with a force plate embedded in the walkway assessed stair 
negotiation. Participants were instructed to ascend the stairs, turn and descend. Three successful trials 
defined as the entire foot of the test leg landing within the boundaries of both force plates with no 
apparent signs of targeting the force plate were collected. The use of handrails was permitted if 
required. Step-over-step (alternate leg on each step) was preferred, and when this was not possible 
step-by-step (both legs on the same step, with the test leg as the leading leg) was permitted.  
 
Participants performed seven successful (defined above) walking trials at self-selected walking speed. 
Each trial was within 10% of mean movement time for that task (Brower timing system, Draper, Utah, 
USA). Walking unaided was prefered; however, due to the lack of a harness, participants were 
permitted to use walking aids if required. 
 
Participants were seated on a standard armchair (height 48cm) aligned next to the force plate with 
their back against the chair and the test leg on the force plate. Participants were instructed to stand 
up, walk 3.6m before turning and returning to the seated position. The use of the chair arm was 
permitted if required.  The transition from sit-to-walk (onset of force to toe-off) from three trials was 




For gait and stair negotiation trials, the stance phase was analysed, defined from initial contact 
(ground reaction force exceeding 20N) to toe-off (ground reaction force subsiding below 20N). The 
stance phase was compartmentalised into four sub-phases; loading (0-15% of stance); early-stance 
(15-40%); mid-stance (40-60%); and late-stance (60-100%) with an additional pre-stance phase of 
150ms prior to initial contact [27]. Stair negotiation was also compartmentalised into transition 
(stance phase on the force plate embedded in the floor), and continuous (stance phase on the force 
plate embedded in the staircase), for ascent and descent. 
 
Muscle strength testing 
 
Participants were seated in the Biodex dynamometer (Biodex 4pro, Biodex Medical Systems Inc, New 
York, USA), and secured using padded straps across the distal thigh, and waist with their knee and hip 
flexed at 50o and 90o respectively. 45o and 30o knee flexion is the typical angle for strength testing due 
to its link between strength and functional performance [28] and least ligamentous strain [29] 
respectively. However, 50o flexion is the angle at which the greatest force is produced [30–32]. The 
dynamometer lever arm was attached to the distal shank approximately an inch above the malleolus, 
aligned to the knee joint axis. Participants were instructed to sit with their arms folded across the 
chest and extend or flex their knee as forcefully as possible, holding for 3s with 30s rest between 
contractions. Following a series of incremental warm-up contractions starting from light building to 
maximal, participants performed a series of 3 maximal voluntary isometric contractions (MVIC’s) for 
the knee flexors and extensors with verbal encouragement provided. For the gastrocnemius, 
participants were seated with their knee fully extended (participants full extension 0-5o) and foot in 
anatomical neutral, secured using strapping across the pelvis and thigh with a resistance, applied to 
the ball of the foot. Following a series of incremental warm-up contractions (as above), participants 
performed a series of 3 plantarflexion MVIC’s lasting 3s with 30s rest, with verbal encouragement. 






All EMG data was Finite Impulse Response Butterworth 4th Order bandpass filtered at 20-450Hz. Root 
mean squared amplitude (RMSamp) was calculated for the stance phase and subsequent sub-phases as 
the RMSamp over the epoch defined above and normalised to MVIC RMSamp. MVIC RMSamp was 
calculated over a 500ms window, 250ms either side of peak torque for the hamstring and quadriceps, 
and 250ms either side of peak EMG amplitude for the gastrocnemius. Peak torque defined as the 
highest torque during the MVIC.   
 
Muscle co-activation was calculated using normalised RMSamp and assessed using the co-activation 
index (1) [33]. The mean RMSamp was calculated for each time epoch as stated above for each muscle. 
The number of samples within each epoch varied between individuals. The grand mean was then 
calculated for each muscle group (flexors, extensors, medial, lateral). For each muscle co-activation 
pairing, the lower of the two values was lowerEMGi and the higher higherEMGi to determine muscle 
co-activation;  knee extensors (VL, RF, VM): flexors (ST, BF) and medial (VM, ST, MG): lateral (VL, BF, 









Means and standard deviations, or frequencies were determined. Skewness, kurtosis, and boxplots 
were obtained to examine the distribution and identify outliers for all variables. Hierarchal sensitivity 
analysis with 1) all data; 2) extreme outliers (>3x inter-quartile range [IQR]) removed; 3) all outliers 
(>1.5x IQR) removed; 4) all outliers and device users removed (‘minimal data’); 5) minimal data with 
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1.5x IQR outliers with low MVIC or reported pain during MVIC included. Device users are defined as 
individuals who used the handrails, chair arm or a walking aid while performing the tasks. Once 
extreme outliers were removed, some variables became significantly different between individuals 
with knee OA and controls (data not presented), this did not change when further outliers were 
removed [34]. The main analysis was run with only extreme (3x IQR) outliers removed. Sensitivity 
analysis was performed with and without device users for each activity separately; there was no 
difference in the results between these analyses. 
 
Independent-samples Student’s t-test was performed to assess the differences in muscle function 
between individuals with knee OA and controls, and between sexes. Levene’s test was performed to 
test heteroscedasticity to assess the appropriateness of linear regression, with the exception of 
mediolateral walking the data did not violate assumptions. Linear regression was performed with 
muscle co-activation as the dependent variable and sex-adjusted muscle strength, age, sex and 
disease status (present/absent of knee OA) as independent variables. Sex and disease status were 
coded as 0/1 (Women/Men, KOA/C). Muscle strength was corrected for sex; the average muscle 
strength for each sex was calculated and subtracted from muscle strength of the individuals. All 
statistical analysis was conducted using SPSS (Version 22.0-23.0, Chicago, USA) with alpha set at 0.05. 




A total of 77 individuals with knee OA and 18 age-matched controls were recruited (Table 1.). MRI was 
performed on 68 individuals with knee OA, of those 24 had Tri compartmental, 14 medial, 3 lateral, 
15 mediolateral OA, and 12 had no knee OA on MRI, however, had been diagnosed as having knee 
OA. Fifteen people had missing data for stairs tasks only (2 controls 11%, 13 knee OA 17%) due to 




Knee OA vs Controls 
 
Individuals with knee OA were weaker than healthy controls for both knee extensors (P=0.001 95%CI 
-0.33, -0.09, Table 1.) and flexors (P=0.001 95%CI -0.18, -0.05). Overall there were limited differences 
in muscle co-activation index between individuals with knee OA and controls, across activities (2/22, 
9%). Sensitivity analysis showed device use did not affect the results. Muscle co-activation index was 
higher in individuals with knee OA for knee flexors-extensors during mid-stance, and mediolateral 
during early-stance during gait only (Figure 1.). 
 
Men vs women 
 
When participants were grouped together by sex regardless of disease status men (extensors 0.72 
[0.23] Nm/kg, flexors 0.43 [0.12] Nm/kg) were stronger than women (extensors 0.57 [0.24] Nm/kg, 
flexors 0.30 [0.12] Nm/kg) for both extensors (P<0.001 95%CI -0.19, -0.08) and flexors (P=0.004, 95%CI 
-0.25, -0.05). Men were stronger than women in individuals with knee OA, there was no difference 
between men and women for controls (Table 1.). 
 
Muscle co-activation index was higher in women compared to men in individuals with knee OA (Figure 
2). The control group women had higher flexor-extensor co-activation index during late stance, and 
continuous stair negotiation. Overall when grouped by sex regardless of disease status muscle co-
activation was higher in women compared to men across all activities except flexor-extensor muscle 
co-activation index during loading and mediolateral muscle co-activation during sit-to-walk (20/22, 
89% significant combinations P<0.05, Figure 3.).  
 




Sex, disease status, age and muscle strength explained 14-36% of the variance in flexor-extensor and 
13-21% of mediolateral muscle co-activation index (power 75.4-99.8%). Bonferroni-Holm corrected 
for multiple comparisons sex, and muscle strength were significant variables within the model (Table 
2.). Sex was significant for flexor-extensor walk, sit-to-walk and continuous stair descent only. Muscle 
weakness was significant for flexor-extensor sit-to-walk, stair descent transition, and mediolateral 
stair ascent. Mediolateral walking violated the assumption of heteroscedasticity and should be 




Muscle co-activation was higher in women with knee OA compared to their male counterparts, 
however, there was no difference between sexes for controls. High muscle co-activation was primarily 
related to sex rather than disease status, where muscle co-activation was higher in women regardless 
of whether knee OA was present. There was no difference in muscle co-activation between individuals 
with knee OA and healthy controls. 
 
Muscle co-activation was higher in women and individuals who were weaker regardless of age and 
disease status. However, age, sex, disease status and muscle strength only explained a small 
proportion of variance in muscle co-activation (13-36%). These results may explain why women are at 
an increased risk of incidence and progression of knee OA, as a result of muscle weakness [16–18], 
higher muscle activation potentially increasing joint loading [5]. However, there was no difference 
between sexes in the control group. Additionally, the sex differences for the knee OA group may be 
explained by unequal group size. While the unequal group size reduced the power for the t-tests, the 




Muscle weakness and female sex were significant predictors of high muscle co-activation. Muscle co-
activation is theorised to be a compensatory mechanism for muscle weakness [5]. Accommodating for 
the diminishing force-generating capabilities associated with knee OA to maintain a certain level of 
function and movement activation patterns [37]. Muscle weakness may, therefore, be the 
contributing factor to high muscle co-activation. High muscle co-activation is thought to increase joint 
load, with detrimental effects on cartilage and joint integrity [7]. These alterations within the joint as 
a result of high muscle co-activation within women may also explain why women are at an increased 
risk of knee replacement [38], and joint space narrowing [39].  
 
Contrary to previous research there was no difference in muscle co-activation between individuals 
with knee OA and healthy controls. When the normalised muscle activation (supplementary file) is 
compared to that of the literature, the mean EMG patterns are similar in amplitude and shape. Within 
our results, large variation between participants can be seen, with the controls demonstrating very 
similar traces. There are several possible explanations. Firstly we did not grade disease severity; 
therefore, the participants spanned the spectrum of disease from very early to awaiting joint 
replacement which may explain the large variation. Additionally, the control group where 
asymptomatic, however, it is plausible that structural joint disease features of knee OA may have been 
present. The combination of these two may explain the lack of significant differences between groups. 
Participants were also permitted to use handrails, chair-arms and walking aids where required. When 
sensitivity analysis was performed on the results with and without the use of assistive devices the 
results did not change. This may be due to participants performing the activities with their usual gait 
patterns, whereas removing assistive devices would have resulted in a more guarded gait pattern. 
 
Muscle co-activation in both the knee OA and control groups in the present study were higher than 
previously reported [5]. A possible explanation is a difference in signal processing, previous studies 
using the same equation and normalisation methods used linear envelope to process the data rather 
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than RMSamp. RMSamp was used because it is believed to be more robust than linear envelope and 
directly linked to electrical power, having more physiological significance over linear envelope [40]. 
Additionally, muscle strength including EMG used for normalisation was assessed at 50o flexion the 
angle at which the greatest force is produced [30–32]. While the previous literature uses 15o 45o, 55o, 
90o [13,37,41–44], or do not report the joint angle [27,45–47]. Alternatively, it has been highlighted 
that asymptomatic individuals may demonstrate knee OA joint damage [48,49], suggesting high 
muscle co-activation may be associated with joint damage regardless of symptoms. Some studies 
define knee OA and control groups using Kellgren and Lawrence scores; this approach was not used 
for the present study which defined controls by the absence of knee OA-related symptoms. 
 
This study has several strengths and limitations. 1. It is a relatively large convenience sample (N=95) 
with substantial sensitivity analysis performed before and during the statistical analysis. 2. Participants 
ranged from newly diagnosed to awaiting a joint replacement, covering a spectrum of disease severity. 
3. MVC’s were performed for the hamstrings and quadriceps, however standardised reference 
contractions were performed for the gastrocnemius to prevent discomfort to the patients. 4. During 
stair negotiation and sit-to-walk transitions, participants were permitted to use the handrails, step-
by-step stair negotiation style and the chair arm. This showed muscle co-activation during normal daily 
living, this meant the dynamic movements were not standardised across the entire sample. Sensitivity 
analysis indicated that this did not affect the results. 5. The muscle co-activation equation used in this 
study is the equation predominantly adopted in the muscle co-activation literature, however, the 
output is non-directional meaning it is unclear which muscle group has the higher muscle activation 
without looking at the raw data. 6. There were differences in the statistical power between the sex 
and disease analysis, where the sex analysis had greater power (38 males versus 57 females) than the 
disease analysis (77 individuals with knee OA versus 18 controls). Using post-hoc power analysis, there 
is potentially only one model where disease status would have reached statistical significance if the 
disease status had the same level of power as the sex analysis. Therefore, this issue would not have 
17 
 
affected the overall conclusions. 7. Mediolateral walking violated the assumption of 
heteroscedasticity for the linear regression model and should, therefore, be interpreted with caution.  
8. Flexor-extensor and mediolateral muscle co-activation may not be independent of each other due 
to the use of the same muscles within the calculations. 
 
In conclusion, high muscle co-activation was associated with female sex and muscle weakness 
regardless of disease status and age. Muscle weakness in women may explain higher muscle co-
activation compared to men and potentially contributes to the explanation of the increased risk of 
incidence and progression of knee OA in women. In contrast to previous research, no statistical 
difference was found in muscle co-activation between individuals with knee OA and age-matched 
controls. Further longitudinal research is required to understand the link between muscle co-
activation, sex, muscle weakness and the associated risk of incidence and progression of knee OA. 
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Table 1.  Patient demographics and activities of daily living data presented as means (SD) 
 Knee OA Controls Knee OA vs 
Control 













P (95% CI) 




62.5 (8.1) 0.545  
(-2.64, 4.97) 








1.66 (0.11) <0.001  
(-19.05, -12.12) 








81.5 (19.4) <0.001  
(-25.36, -8.85) 








29.4 (6.0) 0.650  
(-3.26, 2.04) 










9.3 (9.2) 0.643  
(-5.32, 3.31) 







0.58 (0.23) 0.002  
(-0.27, -0.06) 










0.33 (0.13) <0.001  
(-0.19, -0.08) 




Activities of Daily Living 




1.05 (0.15) 0.314  
(-0.12, 0.04) 




Walking stick use, yes 
(%) # 
1 (1%) 1 (1%) 2 (3%) - 0 0 0 - - 
Chairarm use, Yes (%) # 18 (62%) 35 (73%) 53 (69%) - 6 (67%) 6 (67%) 12 (67%) - - 
Stairs walking style (Knee OA=64 [men=24, women=40] Controls =16 [men=7, women=9]) 
Ascent, SOS (%) # 24 (100%) 35 (88%) 59 (92%) - 7 (100%) 9 (100%) 16 (100%) - - 
Ascent, SBS (%) # 0 5 (12%) 5 (8%) - 0 0 0 - - 
Descent SOS (%) # 23 (96%) 32 (80%) 55 (86%) - 7 (100%) 9 (100%) 16 (100%) - - 
Descent, SBS (%) # 1 (4%) 8 (20%) 9 (14%) - 0 0 0 - - 
Handrail use, Yes (%) # 4 (16%) 22 (55%) 26 (41%) - 1 (14%) 0 1 (6%) - - 




Table 2. Results of regression analysis of muscle co-activation during activities of daily living 
 Hamstrings:quadriceps walk Medial:lateral walka 
 B Coeff SE P B Coeff SE P 
Age 0.651 0.272 0.019 -0.114 0.480 0.812 
Sex -17.924 4.702 <0.001# -19.630 8.349 0.021 
Disease status 3.590 5.892 0.544 -4.668 10.723 0.664 
Quads PT -26.965 10.432 0.012 -60.123 18.373 0.002 
 R2=0.242, P=<0.001* PWR=0.830 R2=0.182, P=0.002* PWR=0.696 
 Hamstrings:quadriceps sit-to-walk Medial:lateral sit-to-walk 
 B Coeff SE P B Coeff SE P 
Age 1.402 0.307 <0.001# 0.290 0.409 0.480 
Sex -14.596 5.337 0.008 -11.300 7.131 0.117 
Disease status 12.569 6.854 0.070 10.611 9.123 0.248 
Quads PT -49.369 11.743 <0.001# -49.446 15.770 0.002 
 R2=0.362, P=<0.001* PWR=0.997 R2=0.131, P=0.018* PWR=0.702 
 Hamstrings:quadriceps SUT Medial:lateral SUT 
 B Coeff SE P B Coeff SE P 
Age 0.498 0.270 0.069 0.112 0.406 0.783 
Sex -19.026 4.613 <0.001 -19.407 7.045 0.008 
Disease status 4.607 5.809 0.430 2.932 8.793 0.740 
Quads PT -36.028 10.330 0.001 -53.913 15.353 0.001# 
 R2=0.314, P=<0.001* PWR=0.923 R2=0.234, P=0.001* PWR=0.680 
 Hamstrings:quadriceps SUC Medial:lateral SUC 
 B Coeff SE P B Coeff SE P 
Age 0.250 0.527 0.698 0.038 0.405 0.925 
Sex -22.753 8.613 0.010 -13.707 7.031 0.055 
Disease status 6.939 10.837 0.524 19.321 8.775 0.031 
Quads PT -38.959 18.920 0.043 -58.569 15.322 <0.001# 
 R2=0.137, P=0.037* PWR=0.715 R2=0.213, P=0.002* PWR=0.668 
 Hamstrings:quadriceps SDC Medial:lateral SDC 
 B Coeff SE P B Coeff SE P 
Age 0.604 0.353 0.091 0.116 0.323 0.721 
Sex -17.192 6.032 0.006 -10.054 5.610 0.078 
Disease status 7.508 7.595 0.326 3.872 7.002 0.582 
Quads PT -41.938 13.321 0.002 -39.801 12.226 0.002 
 R2=0.230, P=0.001* PWR=0.663 R2=0.172, P=0.011* PWR=0.700 
 Hamstrings:quadriceps SDT Medial:lateral SDT 
 B Coeff SE P B Coeff SE P 
Age 0.653 0.424 0.128 0.488 0.456 0.289 
Sex -24.265 7.199 0.001# -17.056 7.902 0.034 
Disease status 1.160 9.147 0.899 -0.130 9.906 0.990 
Quads PT -67.537 15.610 <0.001# -54.768 17.012 0.002 
 R2=0.335, P=<0.001* PWR=0.961 R2=0.206, P=0.003* PWR=0.696 
a – violates assumption of heteroscedasticity; Quads PT – quadriceps peak torque; SUT – stairs ascent 
transition; SUC – stair ascent continuous; SDC – stair descent continous; SDT – stair descent transition; 
β Coeff – beta standardised regression coefficient; SE – standard error; * uncorrected significant 





Figure 1. Muscle co-activation of the A) hamstrings:quadriceps B) medial:lateral across different 
activities for knee OA (Black) and controls (Spotted). Significant differences between knee OA and 
controls * Holm-Bonferroni corrected significant values. 
 
Figure 2. Muscle co-activation of the hamstrings:quadriceps (A-B), medial:lateral (C-D) for individuals 
with osteoarthritis (A-C) and controls (B-D) for women (Black) and men (spotted). Significant sex 
differences * Holm-Bonferroni corrected significant values. 
 
Figure 3. Muscle co-activation of the A) hamstrings:quadriceps B) medial:lateral across different 
activities for women (Black) and men (Spotted) combined regardless of disease activity. Significant 
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